Showing results (91-100 of 211) with videos related to

Sort By:
Pageof 22
Archives of Internal Medicine|October 13, 2006
The FDA and drug safety: a proposal for sweeping changesCurt D Furberg, Arthur A Levin, Peter A Gross, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 11, 2020
The clinical utility of apoB versus LDL-C/non-HDL-CCiaran N Kohli-Lynch, George Thanassoulis, Andrew E Moran, et al.
Clinical Biochemistry|October 19, 2006
Differential impact of plasma triglycerides on HDL-cholesterol and HDL-apo A-I in a large cohortAndré J Tremblay, Allan D Sniderman, Claude Gagné, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Cardiovascular death in dialysis patients: lessons we can learn from AURORAAllan D Sniderman, Amirreza Solhpour, Ahsan Alam, et al.
Clinical Science (London, England : 1979)|September 18, 2007
Non-HDL cholesterol and apoB in dyslipidaemiaAllan D Sniderman, Jean-Charles Hogue, Jean Bergeron, et al.
Journal of the American Geriatrics Society|March 28, 2008
Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: the Cardiovascular Health StudyCurt D Furberg, Jeanenne J Nelson, Cam Solomon, et al.
Preventive Medicine|October 12, 2010
Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physiciansAnthony J Viera, Stacey L Sheridan, Teresa Edwards, et al.
JAMA|January 8, 2004
Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002Randall S Stafford, Curt D Furberg, Stan N Finkelstein, et al.
Pageof 22